Phagenesis
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Enterprise House Manchester Science Park...Phone Number
+44 1618204525Website
www.phagenesis.comRevenue
$7.3 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Phagenesis
Phagenesis specializes in the Phagenyx System, a neurostimulation device designed to improve swallowing safety and efficiency in patients suffering from post-stroke dysphagia. The system utilizes pharyngeal electrical stimulation to restore the brain's control over swallowing, facilitating faster recovery and reducing hospital stays. Targeting healthcare providers, the company aims to enhance patient outcomes through evidence-based interventions. Supported by extensive clinical research, Phagenesis is committed to transforming dysphagia care in clinical settings.Explore more
Phagenesis Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Phagenesis your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Phagenesis has new funding data
Product Launch: Get notified when Phagenesis launches new products
Earning: See what the market has to say on Phagenesis recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Phagenesis
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Phagenesis had a recent Job posting/layoffs
Phagenesis, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Phagenesis has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Check out if Phagenesis is spiking on competitors!
Recommended Actions
Find VP level buyers at Phagenesis
Find more new buyers
Compare Similar Companies to Phagenesis
Compare insights from companies similar to Phagenesis, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Phagenesis is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Phagenesis is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Phagenesis.
Phagenesis financials insights
Gather financial insights about Phagenesis, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2010
Series A
$2.3M
2012
Grant
$1.1M
2013
Series B
$17M
2024
Series D
$42M
Phagenesis Tech Stack
A closer look at the technologies used by Phagenesis
Most Recent Scoops
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Hiring Plans
Phagenesis has more open roles in Medical & Health than it has had at any time in the past 12 months. Areas of expertise include: Clinical Data Analysis, Hospital Medicine, Medical Devices, and Rehabilitation.
Hiring Plans
Hiring Plans
Phagenesis has more open roles in Medical & Health than it has had at any time in the past 12 months.
Hiring Plans
New Hire
Executive Move
Executive Moves, New Hire
Funding
Funding
Phagenesis News & Media
Phagenesis Appoints Stephen Oesterle, MD, to Board of Directors
MedTech Industry Veteran to Support Next Phase of U.S. Growth and Global Expansion NASHVILLE, Tenn., April 29, 2026 /PRNewswire/ -- Phagenesis, a commercial-stage company pioneering neuromodulation therapies for swallowing disorders, today announced the appointment of Stephen N. Oesterle,...Pharyngeal Electrical Stimulation Recognized as Important Tool for Post-Stroke Recovery in New American Heart Association and American Stroke Association Guideline
Inclusion in new Acute Ischemic Stroke guidelines underscores clinical utility of Phagenyx for accelerating recovery from swallowing difficulties (dysphagia) in stroke patients NASHVILLE, Tenn., Jan. 27, 2026 /PRNewswire/ -- Phagenesis, a commercial-stage company with a first-of-its-kind...Phagenesis, Ltd.: Phagenesis Appoints Chad Hoskins as Chief Executive Officer Following ...
Accomplished leader brings strong track record of commercial expansion in the US Company is focused on accelerating uptake of Phagenyx® to treat more patients in the US and EuropePhagenyx® is
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Phagenesis
Sign Up For FreeTo access detailed company insights
Phagenesis specializes in the Phagenyx System, a neurostimulation device designed to improve swallowing safety and efficiency in patients suffering from post-stroke dysphagia. The system utilizes pharyngeal electrical stimulation to restore the brain's control over swallowing, facilitating faster recovery and reducing hospital stays. Targeting heal... Read More
